Understanding Fibromyalgia
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, profound fatigue, sleep disturbances, and cognitive difficulties often called fibro fog. It affects an estimated 4 million adults in the United States, approximately 2 percent of the adult population. Women are diagnosed at roughly twice the rate of men, and symptoms typically appear between ages 20 and 50.
Despite decades of research, fibromyalgia remains one of the most challenging conditions to treat effectively. Standard treatments including medications, physical therapy, and lifestyle modifications provide only partial relief for many patients. This has led researchers and clinicians to explore hyperbaric oxygen therapy as a promising approach that targets the underlying neurological mechanisms driving fibromyalgia symptoms.
The Brain Connection
Advanced neuroimaging studies have revealed that fibromyalgia is fundamentally a disorder of central pain processing. Patients show abnormal activity in brain regions responsible for pain perception, with reduced blood flow to areas that modulate pain signals. This central sensitization means the brain amplifies pain signals from the body, causing normal sensations to be perceived as painful.
HBOT addresses this directly. By delivering oxygen at elevated pressures, HBOT increases cerebral blood flow to the underperforming brain regions identified in fibromyalgia patients. It reduces neuroinflammation that contributes to central sensitization, promotes neuroplasticity allowing the brain to reorganize its pain processing pathways, stimulates the growth of new blood vessels in the brain, and supports mitochondrial function in energy-depleted neural tissue.
What the Research Shows
A landmark study examined fibromyalgia patients who underwent 40 HBOT sessions. Brain SPECT imaging before and after treatment showed significant improvements in blood flow to the brain regions associated with pain processing. Patients reported meaningful reductions in pain severity, improvements in quality of life, and reduced need for pain medications. Some patients experienced complete resolution of their fibromyalgia diagnosis criteria.
Additional studies have confirmed that HBOT can reduce tender point sensitivity, improve sleep quality, enhance cognitive function and reduce fibro fog, increase energy levels and reduce fatigue, and decrease reliance on pain medications. The benefits appear to be long-lasting, with many patients maintaining improvements months after completing treatment. Explore the evidence on our HBOT research library.
Treatment Protocol
The typical HBOT protocol for fibromyalgia involves 40 to 60 sessions delivered five days per week. Each session lasts 60 to 90 minutes at pressures of 2.0 to 2.4 ATA in a medical-grade hyperbaric chamber. Many patients begin noticing improvements in energy and sleep within the first two weeks, with pain reduction becoming more apparent as the treatment course progresses. HBOT also mobilizes stem cells that support neural repair. Learn about what to expect at your first session.
Treatment at National Hyperbaric
Our physicians, Dr. Allan Spiegel and Dr. Montana, have experience treating fibromyalgia patients who have not found adequate relief from conventional therapies. We develop individualized treatment plans and monitor your progress throughout the course. Contact us for a free consultation to discuss whether HBOT may help your fibromyalgia symptoms. Visit our cost and insurance page for coverage details, and learn about our travel for treatment program. View all conditions we treat.